DRKS00026129招募中不适用
HEAL -Highly automated and demand-responsive transport in Bad Birnbach; effects on mobility behavior, social participation, and accessibility and utilization of health care services. - HEA
DB Regio Bus0 个研究点目标入组 200 人开始时间: 2021年9月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 999 Years（—）
- 性别
- All
入选标准
- •Sub-study 1: Residence in the market town of Bad Birnbach, over 18 years of age
- •Sub-study 2: Residence in the market town of Bad Birnbach, over 18 years of age
- •Sub-study 3: over 18 years of age
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A fully automated and web-based intervention for stress managementParticipants from the normal population with a perceived need for stress managementMental and Behavioural DisordersStress, not elsewhere classifiedISRCTN25619675Research Council of Norway (Norway)235
招募中
不适用
AI-based health care system using a pulse wave and Korean Medicine diagnosisKCT0007655Kyung Hee University120
招募中
不适用
Integrated healthcare of new therapies through telemedicine, empowerment, gene therapeutics, registry establishment, drug safety, therapy pathways and reimbursementspinal muscular atrophy, severe combined immunodeficiency due to adenosindesamniase deficiency, metachromatic leukodystrophy, folicular lymphoma, mantle cell lymphoma, diffuse large B-cell lymphoma, other and unspecified types of non-Hodgkin's lymphomaDRKS00030630niversitätsklinikum Heidelberg, Klinik für Hämatologie, Onkologie und Rheumatologie Innere Medizin V650
尚未招募
1 期
A clinical trial to determine the safety and tolerability of GRWD5769 in combination with anticancer treatments in patients with solid malignancies.ACTRN12623001077651Grey Wolf Therapeutics Pty Ltd36
招募中
1 期
A Modular, Multi-part, Multi-arm, Open-label, Phase I/II Study to Evaluate the Safety and Tolerability of GRWD5769 Alone and in Combination with Anticancer Treatments in Patients with Solid MalignanciesSolid malignanciesMedDRA version: 21.1Level: LLTClassification code: 10065147Term: Malignant solid tumor Class: 10029104MedDRA version: 21.1Level: LLTClassification code: 10065143Term: Malignant solid tumour Class: 10029104CTIS2023-504845-30-00Grey Wolf Therapeutics Limited288